AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Champion, HC Pierce, RL Bivalacqua, TJ Murphy, WA Coy, DH Kadowitz, PJ
Citation: Hc. Champion et al., Analysis of responses to hAmylin, hCGRP, and hADM in isolated resistance arteries from the mesenteric vascular bed of the rat, PEPTIDES, 22(9), 2001, pp. 1427-1434

Authors: Ito, T Igarashi, H Pradhan, TK Hou, W Mantey, SA Taylor, JE Murphy, WA Coy, DH Jensen, RT
Citation: T. Ito et al., GI side-effects of a possible therapeutic GRF analogue in monkeys are likely due to VIP receptor agonist activity, PEPTIDES, 22(7), 2001, pp. 1139-1151

Authors: Tulipano, G Bonfanti, C Milani, G Billeci, B Bollati, A Cozzi, R Maira, G Murphy, WA Poiesi, C Turazzi, S Giustina, A
Citation: G. Tulipano et al., Differential inhibition of growth hormone secretion by analogs selective for somatostatin receptor subtypes 2 and 5 in human growth-hormone-secretingadenoma cells in vitro, NEUROENDOCR, 73(5), 2001, pp. 344-351

Authors: Gulec, SA Drouant, GJ Fuselier, J Anthony, CT Heneghan, J DelCarpio, JB Coy, DH Murphy, WA Woltering, EA
Citation: Sa. Gulec et al., Antitumor and antiangiogenic effects of somatostatin receptor-targeted in situ radiation with In-111-DTPA-JIC 2DL, J SURG RES, 97(2), 2001, pp. 131-137

Authors: Rajeswaran, WG Hocart, SJ Murphy, WA Taylor, JE Coy, DH
Citation: Wg. Rajeswaran et al., N-methyl scan of somatostatin octapeptide agonists produces interesting effects on receptor subtype specificity, J MED CHEM, 44(9), 2001, pp. 1416-1421

Authors: Rajeswaran, WG Hocart, SJ Murphy, WA Taylor, JE Coy, DH
Citation: Wg. Rajeswaran et al., Highly potent and subtype selective ligands derived by N-methyl scan of a somatostatin antagonist, J MED CHEM, 44(8), 2001, pp. 1305-1311

Authors: Bivalacqua, TJ Champion, HC Purohit, SK Murphy, WA Coy, DH Kadowitz, PJ Hellstrom, WJG
Citation: Tj. Bivalacqua et al., Nitric oxide-mediated erectile effects of galantide but not galanin in vivo, NITRIC OXID, 4(2), 2000, pp. 94-102

Authors: Altman, RD Bloch, DA Hochberg, MC Murphy, WA
Citation: Rd. Altman et al., Prevalence of pelvic Paget's disease of bone in the United States, J BONE MIN, 15(3), 2000, pp. 461-465

Authors: Woltering, EA O'Dorisio, MS Murphy, WA Chen, F Drouant, GJ Espenan, GD Fisher, DR Sharma, C Diaco, DS Maloney, TM Fuselier, JA Nelson, JA O'Dorisio, TM Coy, DH
Citation: Ea. Woltering et al., Synthesis and characterization of multiply-tyrosinated, multiply-iodinatedsomatostatin analogs, J PEPT RES, 53(2), 1999, pp. 201-213

Authors: Belloni, AS Andreis, PG Meneghelli, V Champion, HC Kadowitz, PJ Coy, DH Murphy, WA Nussdorfer, GG
Citation: As. Belloni et al., Adrenomedullin and calcitonin gene-related peptide (CGRP) interact with a common receptor of the CGRP1 subtype in the human adrenal zona glomerulosa, ENDOCRINE R, 25(1), 1999, pp. 29

Authors: Belloni, AS Rossi, GP Andreis, PG Aragona, F Champion, HC Kadowitz, PJ Murphy, WA Coy, DH Nussdorfer, GG
Citation: As. Belloni et al., Proadrenomedullin N-terminal 20 peptide (PAMP), acting through PAMP(12-20)-sensitive receptors, inhibits Ca2+-dependent, agonist-stimulated secretionof human adrenal glands, HYPERTENSIO, 33(5), 1999, pp. 1185-1189

Authors: Hocart, SJ Jain, R Murphy, WA Taylor, JE Coy, DH
Citation: Sj. Hocart et al., Highly potent cyclic disulfide antagonists of somatostatin, J MED CHEM, 42(11), 1999, pp. 1863-1871

Authors: Belloni, AS Andreis, PG Rossi, GP Champion, HC Kadowitz, PJ Murphy, WA Coy, DH Nussdorfer, GG
Citation: As. Belloni et al., Structure-activity relationships of adrenomedullin in the adrenal gland, ENDOCRINE R, 24(3-4), 1998, pp. 729-730
Risultati: 1-13 |